Generic Drug Makers India
- All
- News
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
- Tuesday October 12, 2021
- India News | Reuters
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
www.ndtv.com
-
Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
- Wednesday June 24, 2020
- India News | Reuters
Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
-
www.ndtv.com
-
Lupin Looks To Clean Up Its Act As FDA Steps Up Inspections
- Sunday July 9, 2017
- India News | Thomson Reuters
Often dubbed "the pharmacy of the world", India is home to the most FDA-approved plants outside of the United States
-
www.ndtv.com
-
India's 100 Richest Includes Only 4 Women
- Thursday September 24, 2015
- India News | Press Trust of India
Four women feature in this year's Forbes list of 100 richest Indians including O P Jindal group Chairperson Savitri Jindal and generic drugs maker USV Pharma Chairperson Leena Tewari.
-
www.ndtv.com
-
Ranbaxy, Teva settle New York antitrust drug claims
- Thursday February 20, 2014
- World News | Agence France-Presse
Generic drug makers Ranbaxy of India and Teva of Israel have agreed to settle allegations they made an illegal pact to restrict competition in New York state.
-
www.ndtv.com
-
Ranbaxy whistle-blower says drug maker faked data
- Thursday November 7, 2013
- India News | Indo-Asian News Service
An Indian origin whistle-blower, who exposed a massive fraud by Ranbaxy, has accused the drug maker of faking test results for approval by the US drug regulator.
-
www.ndtv.com
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
- Tuesday October 12, 2021
- India News | Reuters
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
www.ndtv.com
-
Hyderabad-Based Hetero Prices Generic COVID-19 Drug At Rs 5,400 Per Vial
- Wednesday June 24, 2020
- India News | Reuters
Hyderabad-based Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at Rs 5,400 ($71) per 100-milligram vial, the drug maker said on Wednesday, as it prepares to ship them to hospitals in the country.
-
www.ndtv.com
-
Lupin Looks To Clean Up Its Act As FDA Steps Up Inspections
- Sunday July 9, 2017
- India News | Thomson Reuters
Often dubbed "the pharmacy of the world", India is home to the most FDA-approved plants outside of the United States
-
www.ndtv.com
-
India's 100 Richest Includes Only 4 Women
- Thursday September 24, 2015
- India News | Press Trust of India
Four women feature in this year's Forbes list of 100 richest Indians including O P Jindal group Chairperson Savitri Jindal and generic drugs maker USV Pharma Chairperson Leena Tewari.
-
www.ndtv.com
-
Ranbaxy, Teva settle New York antitrust drug claims
- Thursday February 20, 2014
- World News | Agence France-Presse
Generic drug makers Ranbaxy of India and Teva of Israel have agreed to settle allegations they made an illegal pact to restrict competition in New York state.
-
www.ndtv.com
-
Ranbaxy whistle-blower says drug maker faked data
- Thursday November 7, 2013
- India News | Indo-Asian News Service
An Indian origin whistle-blower, who exposed a massive fraud by Ranbaxy, has accused the drug maker of faking test results for approval by the US drug regulator.
-
www.ndtv.com